Parker Waichman LLP

Vytorin Makers Spent Millions on Medical Education

Vytorin Makers Spent Millions on Medical Education Merck & Co. and Schering-Plough, the makers of Vytorin, spent millions over the past four years to educate doctors about  the latest treatments for heart disease, according to The Wall Street Journal. Critics of the pharmaceutical industry assert that  marketing, not medical education, is usually behind such generosity. According […]

Vytorin

Vytorin Makers Spent Millions on Medical Education Merck & Co. and Schering-Plough, the makers of Vytorin, spent millions over the past four years to educate doctors about  the latest treatments for heart disease, according to The Wall Street Journal. Critics of the pharmaceutical industry assert that  marketing, not medical education, is usually behind such generosity.

According to the Journal, Merck and Schering-Plough paid out a total of $60 million to a small group of medical schools and health groups, including Harvard University and the American Heart Association.  The funds were used for Continuing Medical Education, or CME. Doctors are required to take CME courses in order to stay current with the latest advances in medical treatments.

Critics of industry funded-CME courses

Critics of industry funded-CME courses say that the practice could influence doctors prescribing habits, and have charged that the courses sometimes highlight the funding companies’ medications over competitors. But Merck,  like many other drug makers, insists it has no input into the content of the courses it funds, The Wall Street Journal said.

The Merck and Schering-Plough CME funding was disclosed in a report released by the Senate Special Committee on Aging. “These documents remove any doubt that, at least in this case, when drug companies fund continuing medical education, they see it as money well spent on marketing their latest blockbuster drug,” said Sen. Herb Kohl, D-WI, chairman of the Special Committee. Kohl, along with Sen. Chuck Grassley, R.-Iowa, has bee pushing for language in Senate health-care legislation to require companies to disclose such payments, the Journal said.

The CME courses Merck and Schering-Plough funded focused on treatment options for heart disease.  According to the Journal, the company’s cholesterol drug, Vytorin, has  been cited by some in Congress as an example of why there needs to be more transparency regarding the medical industry’s financial relationship with doctors, medical schools and medical groups.

Vytorin’s supposed benefits have been the subject of controversy

Vytorin’s supposed benefits have been the subject of controversy since the ENHANCE study was released in January 2008. ENHANCE found that the drug was no better than a cheaper, generic statin in preventing clogged arteries, and raised serious questions about the effectiveness of  Vytorin. What’s more, Merck and Schering-Plough delayed releasing ENHANCE for more than a year, even though the trial was actually completed in 2006.

The ENHANCE controversy spawned scores of lawsuits against Merck and Schering-Plough. Many accused the companies of marketing Vytorin and Zetia in a misleading fashion and failing to disclose the results of ENHANCE in a timely manner. We reported last month that Merck and Schering-Plough agreed to pay $41.5 million to settle class-action lawsuits stemming from that debacle.  Several committees in Congress are investigating Vytorin marketing efforts.

Need Legal Help Regarding Vytorin?

The personal injury attorneys at Parker Waichman LLP offer free, no-obligation case evaluations. For more information, fill out our online contact form or call 1-800-YOURLAWYER (1-800-968-7529).

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Excellent service from the best lawyers in New York Their customer service is excellent Especially Julie, Maryann, Dawn and the hardest the best JORGE Thank you very much to all
Jhony Gonzalez
6 months ago
5 Star Reviews 150
I want copy for court cases for vaccines injuries . My little girl have signs of GBS
Wael Jaber
a year ago
5 Star Reviews 150
Nicole Copertino handled my case Professionally. She is friendly and knowledgeable
vance calvin
a year ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038